Mondelez International, Inc. (NASDAQ: MDLZ), the prominent Chicago-based multinational confectionery, food, and beverage company, is scheduled to disclose its financial performance for the fourth quarter after the closing bell on Tuesday, February 3.
Analyst consensus forecasts project that the company will report an earnings per share (EPS) figure of approximately 70 cents for the quarter, reflecting a notable increase from 65 cents earned per share during the same quarter last year. The projected revenue stands at around $10.29 billion, which represents growth compared to the $9.6 billion recorded in the corresponding period of the previous year.
Adding to the corporate developments, Mondelez recently appointed Luca Zaramella as its Chief Operating Officer (COO) and Chief Financial Officer (CFO) on January 29, a strategic decision potentially signaling a new phase in the company’s operational and financial management.
In terms of market performance, Mondelez’s shares experienced a modest gain of 0.4 percent, closing at $58.69 on the trading session immediately before the earnings announcement.
Investors and analysts now keenly await the company's official disclosures, which will either validate or challenge the revised expectations that brokerage firms and industry experts have outlined.
Detailed analyst sentiment provides insight into the market's anticipation of the company's future trajectory. According to Benzinga's compilation of analyst ratings, several top analysts have updated their views and price targets for Mondelez in the weeks leading up to the earnings report.
- Brian Holland of DA Davidson assigned a Neutral rating to Mondelez's stock with a price target of $62; Holland carries an analyst accuracy rate of 52% and maintained this outlook on January 29, 2026.
- Robert Moskow from TD Cowen continues to endorse Mondelez as a Buy, though he lowered the price target from $68 to $62 on January 8, 2026. Moskow holds a 65% accuracy rate in his analyses.
- John Baumgartner of Mizuho reiterated his Outperform rating while adjusting the price target downward from $70 to $67 on January 8, 2026. Baumgartner’s accuracy stands at 57%.
- Chris Carey of Wells Fargo maintained an Overweight rating but decreased the price target significantly from $72 to $62 as of January 5, 2026; Carey’s accuracy is reported at 61%.
- Megan Alexander at Morgan Stanley retains an Overweight rating and slightly lowered the price objective from $68 to $64 on December 11, 2025; her analyst accuracy is 64%.
The spectrum of analyst adjustments, primarily concerning price targets, reflects cautious attitudes tempered by competitive market dynamics and possibly evolving operational factors within Mondelez.
Monitoring tools, such as Benzinga’s Analyst Stock Ratings page, enable investors to sort and evaluate these ratings by various criteria, including ticker, firm, rating change, and more, providing comprehensive insights into the consensus market sentiment and analyst confidence.
While detailed financial metrics and strategic plans for the upcoming quarter will be revealed during the earnings release, the currently accessible data points highlight mid-single digit growth in EPS and revenue year-over-year, a healthy sign in the consumer packaged goods sector.
Nonetheless, the stock price movements and analyst revisions caution that uncertainties remain. Investors should consider the following risks and uncertainties before making investment decisions:
- Market Reaction to Earnings: The potential for the company to underperform or exceed the current EPS and revenue projections could create volatility in share price.
- Effect of Executive Turnover: The recent appointment of Luca Zaramella as COO and CFO might imply strategic shifts, the outcomes of which are yet to be determined.
- Analyst Target Adjustments: The downward revisions in price targets by multiple analysts suggest tempered confidence about near-term stock appreciation potential.
- Macro-Economic Factors: External market conditions impacting consumer demand and raw material costs could influence Mondelez’s performance beyond internal factors.
In summary, Mondelez stands at a crossroads with investors and analysts focused on upcoming disclosures amid an environment of moderate optimism balanced by prudent caution. The impending earnings report will shed light on whether the company can sustain its growth trends and validate the recent price target recalibrations.